V3 LOOP REGION OF THE HIV-1 GP120 ENVELOPE PROTEIN IS ESSENTIAL FOR VIRUS INFECTIVITY

被引:93
作者
IVANOFF, LA
DUBAY, JW
MORRIS, JF
ROBERTS, SJ
GUTSHALL, L
STERNBERG, EJ
HUNTER, E
MATTHEWS, TJ
PETTEWAY, SR
机构
[1] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
[2] UNIV ALABAMA,DEPT MICROBIOL,UAB STN,BIRMINGHAM,AL 35294
关键词
D O I
10.1016/0042-6822(92)90444-T
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The mechanism by which HIV-1 mediates cell fusion and penetrates target cells, subsequent to receptor (CD4) binding, is not well understood. However, neutralizing antibodies, which recognize the principal neutralizing determinants of the gpl 20 envelope protein (the V3 loop region, residues 296 to 331), have been shown to effectively block cell fusion and virus infectivity independent of the initial gpl20-CD4 binding. To investigate the role of the V3 loop in an HIV infection, a series of site-specific mutations were introduced into the HIV-1 envelope gene. Specifically, each residue (312 to 315) in the strongly conserved tetrapeptide sequence, GPGR, which is positioned in the center of the V3 loop domain was individually altered. The processing, transport, and CD4 binding properties of the mutant envelope proteins were comparable to those of the wild-type protein, however, none of the mutants were able to form syncytia in the HeLa-T4 assay. Molecular HIV-1 clones containing mutations altering the G312, G314, or R315 residues produced noninfectious virions, whereas a clone with a P313A mutation was found to be infectious. These results demonstrate that certain V3 loop mutations can be lethal and clearly indicate that this region of the HIV-1 gpl 20 protein is essential for virus infectivity. © 1992.
引用
收藏
页码:423 / 432
页数:10
相关论文
共 48 条
[1]   A CD4 DOMAIN IMPORTANT FOR HIV-MEDIATED SYNCYTIUM FORMATION LIES OUTSIDE THE VIRUS BINDING-SITE [J].
CAMERINI, D ;
SEED, B .
CELL, 1990, 60 (05) :747-754
[2]   PHENOTYPIC VARIATION IN THE RESPONSE TO THE HUMAN IMMUNODEFICIENCY VIRUS AMONG DERIVATIVES OF THE CEM T-CELL AND WIL-2 B-CELL LINES [J].
CHAFFEE, S ;
LEEDS, JM ;
MATTHEWS, TJ ;
WEINHOLD, KJ ;
SKINNER, M ;
BOLOGNESI, DP ;
HERSHFIELD, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (02) :605-621
[3]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[4]  
CLEMENTS GJ, 1991, AIDS RES HUM RETROV, V57, P3
[5]   THE CD4 (T4) ANTIGEN IS AN ESSENTIAL COMPONENT OF THE RECEPTOR FOR THE AIDS RETROVIRUS [J].
DALGLEISH, AG ;
BEVERLEY, PCL ;
CLAPHAM, PR ;
CRAWFORD, DH ;
GREAVES, MF ;
WEISS, RA .
NATURE, 1984, 312 (5996) :763-767
[6]   ENTRY INTO HOST-CELLS OF SINDBIS VIRUS, VESICULAR STOMATITIS-VIRUS AND SENDAI VIRUS [J].
FAN, DP ;
SEFTON, BM .
CELL, 1978, 15 (03) :985-992
[7]   CHARACTERIZATION OF THE FUSION DOMAIN OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN GP41 [J].
FREED, EO ;
MYERS, DJ ;
RISSER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) :4650-4654
[8]   IDENTIFICATION OF THE PRINCIPAL NEUTRALIZING DETERMINANT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AS A FUSION DOMAIN [J].
FREED, EO ;
MYERS, DJ ;
RISSER, R .
JOURNAL OF VIROLOGY, 1991, 65 (01) :190-194
[9]   HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 NEUTRALIZATION EPITOPE WITH CONSERVED ARCHITECTURE ELICITS EARLY TYPE-SPECIFIC ANTIBODIES IN EXPERIMENTALLY INFECTED CHIMPANZEES [J].
GOUDSMIT, J ;
DEBOUCK, C ;
MELOEN, RH ;
SMIT, L ;
BAKKER, M ;
ASHER, DM ;
WOLFF, AV ;
GIBBS, CJ ;
GAJDUSEK, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (12) :4478-4482
[10]   NEW TECHNIQUE FOR ASSAY OF INFECTIVITY OF HUMAN ADENOVIRUS 5 DNA [J].
GRAHAM, FL ;
VANDEREB, AJ .
VIROLOGY, 1973, 52 (02) :456-467